MEDTRONIC $MDT JUST REPORTED Q1 EARNINGS * Revenue: $9.76B (+13.7% YoY), beating est. of $9.54B 🟢 * Adj EPS: $1.45 (+15.1% YoY), beating est. of $1.39 🟢 * Cardiovascular Revenue: $3.9B (+19.5% YoY) * Diabetes Revenue: $843M (+16.9% YoY) * Cardiac Ablation Solutions: +88% YoY * Free Cash Flow: $1.3B Raises FY27 Guidance: * Adj EPS: $5.94-$6.00, vs est. of $5.95 * Organic Revenue Growth: 7.25%-7.75%, up from 6.75%-7.25% Key Updates: * Announced ~$700M Cornerstone Robotics deal, securing rights to distribute the Sentire surgical robot in select markets outside the U.S. * Hugo robotic procedures expected to exceed 50,000 globally by fiscal year-end * Q1 included an extra fiscal week, which added ~$570M to organic revenue growth